论文标题
表征美国SARS-COV-2突变
Characterizing SARS-CoV-2 mutations in the United States
论文作者
论文摘要
自2020年1月初首次测序以来,严重的急性呼吸综合征冠状病毒2(SARS-COV-2)一直在突变。遗传变异已发展为具有不同特性的几个不同的簇。由于美国(美国)在全球受感染的病毒感染患者数量最多,因此必须了解美国SARS-COV-2。我们透露,使用基因分型,序列平衡,时间进化,$ k $ - 均值聚类,蛋白质折叠稳定性,代数拓扑和网络理论,我们透露,美国SARS-COV-2在中国首次在中国(2案例),新加坡(2个案例)和英国KIRDER(1个案例)(2案例)和1个案例(2案例),在中国首次检测到美国SARS-COV-2五个基质和五个美国最高的SARS-COV-2突变。接下来的三个美国SARS-COV-2突变首先在美国检测到。这八个最高突变属于两个断开的组。由5个并发突变组成的第一组盛行,而另一组具有3个并发突变的组逐渐消失。我们的分析表明,女性免疫系统比男性对SARS-COV-2感染的反应更为活跃。我们确定ORF8上的27964c $> $ t-(S24L)的最高突变之一具有异常强大的性别依赖性。基于对峰值蛋白的所有突变的分析,我们进一步发现,美国四个SASR-COV-2底物中的三个变得更具感染性。我们的研究要求有效的病毒控制和在美国包含策略。
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been mutating since it was first sequenced in early January 2020. The genetic variants have developed into a few distinct clusters with different properties. Since the United States (US) has the highest number of viral infected patients globally, it is essential to understand the US SARS-CoV-2. Using genotyping, sequence-alignment, time-evolution, $k$-means clustering, protein-folding stability, algebraic topology, and network theory, we reveal that the US SARS-CoV-2 has four substrains and five top US SARS-CoV-2 mutations were first detected in China (2 cases), Singapore (2 cases), and the United Kingdom (1 case). The next three top US SARS-CoV-2 mutations were first detected in the US. These eight top mutations belong to two disconnected groups. The first group consisting of 5 concurrent mutations is prevailing, while the other group with three concurrent mutations gradually fades out. Our analysis suggests that female immune systems are more active than those of males in responding to SARS-CoV-2 infections. We identify that one of the top mutations, 27964C$>$T-(S24L) on ORF8, has an unusually strong gender dependence. Based on the analysis of all mutations on the spike protein, we further uncover that three of four US SASR-CoV-2 substrains become more infectious. Our study calls for effective viral control and containing strategies in the US.